The need for translational research on drug-drug interactions

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 5, 2012, Pages 771-773

  Hennessy, S ^a   Flockhart, D A ^b  

^a Center for Clinical Epidemiology   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; RECOMBINANT ENZYME; ROFECOXIB; WARFARIN;

CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; COMPUTER MODEL; DRUG DRUG INTERACTION; DRUG RESEARCH; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; HEART INFARCTION; HUMAN; IN VITRO STUDY; NOTE; PHARMACIST; PHARMACODYNAMICS; PHARMACOEPIDEMIOLOGY; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; RHABDOMYOLYSIS; TRANSLATIONAL RESEARCH; UNITED STATES;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PLATELET AGGREGATION INHIBITORS; PYRIDINES; TICLOPIDINE;

EID: 84859964620     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.39     Document Type: Note

References (10)

1. Kit, B.K., Ogden, C.L. & Flegel, K.M. Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008. Ann. Epidemiol. 22, 112-119 (2012).
2. Gurwitz, J.H. et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289, 1107-1116 (2003).
3. Jankel, C.A. & Fitterman, L.K. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf. 9, 51-59 (1993).
4. Equals Three Communications for the American Society of Health-System Pharmacists. Top Patient Concerns 2002: Omnibus Survey Results 〈http://www.ashp.org/s-ashp/docs/files/ PR-ResearchReport.pdf〉 (2002).
5. Langdorf, M.I., Fox, J.C., Marwah, R.S., Montague, B.J. & Hart, M.M. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad. Emerg. Med. 7, 1321-1329 (2000).
6. Holbrook, A. et al. Systematic overview of warfarin and its drug and food interactions. Arch. Intern. Med. 165, 1095-1106 (2005).
7. Abarca, J. et al. Concordance of major drug interaction classifications among drug interaction compendia. J. Am. Pharm. Assoc. 44, 136-141 (2004).
8. Selker, H.P. Beyond translational research from T1 to T4: beyond "separate but equal" to integration (Ti). Clin. Transl. Sci. 3, 270-271 (2010).
9. Floyd, J.S. et al. A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel. Clin. Pharmacol. Ther. 91, 896-904 (2012).
10. Tatonetti, N.P. et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin. Pharmacol. Ther. 90, 133-142 (2011).